Overview

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Status:
Completed
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if adding stavudine (d4T) to anti-HIV drug regimens (with or without zidovudine, ZDV) can improve symptoms of AIDS Dementia Complex (ADC, problems involving the brain or spinal cord) in HIV-positive patients.
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Stavudine